Dr. Gezzer Ortega

Jin He, M.D., Ph.D., is a professor of surgery at the Johns Hopkins University School of Medicine and is the Division Chief of Hepato-Pancreato-Biliary & Gastrointestinal Surgical Oncology. Dr. He specializes in diseases and tumors of the pancreas, liver, bile duct, and gallbladder. He performs open as well as minimally invasive (robotic and laparoscopic) surgery, including the Whipple procedure. Dr. He received his medical degree from Beijing Medical University and a Ph.D. in oncology from Fudan University Shanghai Medical College. He completed the Halsted general surgery residency training at Johns Hopkins, followed by an ACGME accredited fellowship in complex general surgical oncology at Johns Hopkins. Dr. He is the John Cameron Professor of Alimentary Tract Diseases. Dr. He’s research focuses on personalized treatment through stratifying pancreatic tumors on their genetic features. He holds several patents in anti-cancer vascular targeting agents and has published extensively in peer-reviewed journals and lectured internationally. He serves on several national committees, including the NCCN panel on neuroendocrine tumors and the Alliance for Clinical Trials in Oncology. Dr. He is rated as an Elite provider by MediFind in Splenectomy. His top areas of expertise are Pancreatic Cancer, Neuroendocrine Tumor, Cholangiocarcinoma (Bile Duct Cancer), Pancreatectomy, and Pancreaticoduodenectomy.

George Younan is a General Surgeon and a Surgical Oncologist in Arlington, Virginia. Dr. Younan is rated as a Distinguished provider by MediFind in Splenectomy. His top areas of expertise are Accessory Pancreas, Pancreas Divisum, Esophageal Cancer, Pancreatectomy, and Hernia Surgery.

Brian Englum is a Pediatric Surgeon and a General Surgeon in Baltimore, Maryland. Dr. Englum is rated as an Advanced provider by MediFind in Splenectomy. His top areas of expertise are Hereditary Spherocytosis, Post-Splenectomy Syndrome, Gastroschisis, Lung Transplant, and Small Bowel Resection. Dr. Englum is currently accepting new patients.